Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Utility of Diffusion-weighted MR Imaging

Not Applicable

Terminated

Conditions: DWM

Interventions: Device: Magnetic Resonance Scanner

First Posted Date: 2017-03-14

Last Posted Date: 2021-02-18

Lead Sponsor: University of Chicago

Target Recruit Count: 3

Registration Number: NCT03078868

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

TMP-Visitas al Hogar

Not Applicable

Completed

Conditions: Language Development

Interventions: Behavioral: Treinta Millones de Palabras - Visitas al Hogar

First Posted Date: 2017-03-10

Last Posted Date: 2023-05-10

Lead Sponsor: University of Chicago

Target Recruit Count: 91

Registration Number: NCT03076268

Locations: 🇺🇸
Thirty Million Words® Initiative at the University of Chicago Medicine, Chicago, Illinois, United States

Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer

Phase 2

Withdrawn

Conditions: Breast Cancer
Breast Cancer Stage III
Breast Cancer Stage II

Interventions: Drug: FEC
Drug: Perjeta
Drug: LHRH agonist
Drug: Paclitaxel
Drug: Carboplatin
Drug: Tamoxifen
Drug: Herceptin SC
Drug: Letrozole

First Posted Date: 2017-02-23

Last Posted Date: 2019-04-22

Lead Sponsor: University of Chicago

Registration Number: NCT03058939

Locations: 🇳🇬
Lagos State University College of Medicine, Ikeja, Lagos State, Nigeria

Trial Comparing Routine Intraoperative Transesophageal Echocardiography During Radical Cystectomy to Standard of Care

Not Applicable

Completed

Conditions: Cardiac and Pulmonary Complications. Central Venous Line Insertion. Gastrointestinal Recovery

Interventions: Other: Transesophageal echocardiography

First Posted Date: 2017-02-20

Last Posted Date: 2023-02-23

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT03058250

Effects of MDMA on Emotional and Social Memories

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: MDMA
Drug: Placebo

First Posted Date: 2017-02-13

Last Posted Date: 2018-06-29

Lead Sponsor: University of Chicago

Target Recruit Count: 84

Registration Number: NCT03050541

A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients

Phase 2

Completed

Conditions: Stem Cell Transplant Complications

Interventions: Drug: Placebo Wipe
Drug: Chlorhexidine Gluconate 2% Wipe

First Posted Date: 2017-01-25

Last Posted Date: 2020-12-10

Lead Sponsor: University of Chicago

Target Recruit Count: 50

Registration Number: NCT03030989

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life

Not Applicable

Completed

Conditions: Continous Flow Left Ventricular Device

Interventions: Procedure: Hemodynamic-Echo Ramp Testing -
Procedure: Echo Guided Testing

First Posted Date: 2017-01-13

Last Posted Date: 2019-04-10

Lead Sponsor: University of Chicago

Target Recruit Count: 40

Registration Number: NCT03021239

Locations: 🇺🇸
Stanford Medical Center, Stanford, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
UC San Diego Medical Center, San Diego, California, United States

and more 5 locations

Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses

Phase 4

Terminated

Conditions: Multiple Sclerosis

Interventions: Drug: ACTHar

First Posted Date: 2017-01-13

Last Posted Date: 2024-05-16

Lead Sponsor: University of Chicago

Target Recruit Count: 5

Registration Number: NCT03021317

Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma

Phase 1

Recruiting

Conditions: Malignant Glioma of Brain

Interventions: Drug: Acetazolamide
Drug: Temozolomide

First Posted Date: 2017-01-05

Last Posted Date: 2024-05-13

Lead Sponsor: University of Chicago

Target Recruit Count: 60

Registration Number: NCT03011671

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring

Not Applicable

Completed

Conditions: Sleep Quality

Interventions: Behavioral: Usual Care
Behavioral: Risk Stratification

First Posted Date: 2017-01-05

Last Posted Date: 2020-03-27

Lead Sponsor: University of Chicago

Target Recruit Count: 166

Registration Number: NCT03010774

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy